Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Struikmans

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|January 30, 2017
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancersMarc B I Lobbes, Ingeborg J H Vriens, Annelotte C M van Bommel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancersIngeborg J H Vriens, Kristien Keymeulen, Marc B I Lobbes, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2017
Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer PatientsJudith G Middelburg, Mirjam E Mast, Maaike de Kroon, et al.
Journal of the National Cancer Institute|July 28, 2021
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925Philip M Poortmans, Henk Struikmans, Peter De Brouwer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Breast cancer in pregnancy: recommendations of an international consensus meetingFrédéric Amant, Sarah Deckers, Kristel Van Calsteren, et al.
The Lancet. Oncology|December 16, 2014
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialHarry Bartelink, Philippe Maingon, Philip Poortmans, et al.
Breast Cancer Research and Treatment|October 1, 2014
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patientsMirjam E Mast, Eline J Vredeveld, Herman M Credoe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2008
Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centersM Loes van Kempen-Harteveld, Ronald Brand, Henk B Kal, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|January 30, 2017
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancersMarc B I Lobbes, Ingeborg J H Vriens, Annelotte C M van Bommel, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2017
Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancersIngeborg J H Vriens, Kristien Keymeulen, Marc B I Lobbes, et al.
International Journal of Radiation Oncology, Biology, Physics|April 4, 2017
Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer PatientsJudith G Middelburg, Mirjam E Mast, Maaike de Kroon, et al.
Journal of the National Cancer Institute|July 28, 2021
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925Philip M Poortmans, Henk Struikmans, Peter De Brouwer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trialHeather A Jones, Ninja Antonini, Augustinus A M Hart, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2010
Breast cancer in pregnancy: recommendations of an international consensus meetingFrédéric Amant, Sarah Deckers, Kristel Van Calsteren, et al.
The Lancet. Oncology|December 16, 2014
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialHarry Bartelink, Philippe Maingon, Philip Poortmans, et al.
Breast Cancer Research and Treatment|October 1, 2014
Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patientsMirjam E Mast, Eline J Vredeveld, Herman M Credoe, et al.
European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 26, 2008
Results of hematopoietic stem cell transplantation after treatment with different high-dose total-body irradiation regimens in five Dutch centersM Loes van Kempen-Harteveld, Ronald Brand, Henk B Kal, et al.
Pageof 7